2008 Clinical Practice Guidelines - Canadian Diabetes Association

2008 CLINICAL PRACTICE GUIDELINES
S176
progression of retinopathy. The Diabetes in Early Pregnancy
Study. National Institute of Child Health and Human
Development Diabetes in Early Pregnancy Study. Diabetes Care.
1995;18:631-637.
26. Lövestam-Adrian M, Agardh CD, Aberg A, et al. Pre-eclampsia
is a potent risk factor for deterioration of retinopathy during
pregnancy in type 1 diabetic patients. Diabetic Med. 1997;
14:1059-1065.
27. Rosenn B, Miodovnik M, Kranias G, et al. Progression of diabetic
retinopathy in pregnancy: association with hypertension
in pregnancy. Am J Obstet Gynecol. 1992;166:1214-1218.
28. Cundy T, Slee F, Gamble G, et al. Hypertensive disorders of
pregnancy in women with type 1 and type 2 diabetes. Diabet
Med. 2002;19:482-489.
29. Sibai BM, Caritis S, Hauth J, et al. Risks of preeclampsia and
adverse neonatal outcomes among women with pregestational
diabetes mellitus. National Institute of Child Health and
Human Development Network of Maternal-Fetal Medicine
Units. Am J Obstet Gynecol. 2000;182:364-369.
30. Schröder W, Heyl W, Hill-Grasshoff B, et al. Clinical value of
detecting microalbuminuria as a risk factor for pregnancyinduced
hypertension in insulin-treated diabetic pregnancies.
Eur J Obstet Gynecol Reprod Biol. 2000;91:155-158.
31. How HY, Sibai B, Lindheimer M, et al. Is early-pregnancy proteinuria
associated with an increased rate of preeclampsia in
women with pregestational diabetes mellitus? Am J Obstet
Gynecol. 2004;190:775-778.
32. Chobanian AV, Bakris GL, Black HR, et al; Joint National
Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure. National Heart, Lung, and
Blood Institute; National High Blood Pressure Education
Program Coordinating Committee. Seventh report of the Joint
National Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure. Hypertension. 2003;
42:1206-1252.
33. Ekbom P, Damm P, Feldt-Rasmussen B, et al. Pregnancy outcome
in type 1 diabetic women with microalbuminuria.
Diabetes Care. 2001;24:1739-1744.
34. Dunne FP, Chowdhury TA, Hartland A, et al. Pregnancy outcome
in women with insulin-dependent diabetes mellitus
complicated by nephropathy. QJM. 1999;92:451-454.
35. Bagg W, Neale L, Henley P, et al. Long-term maternal outcome
after pregnancy in women with diabetic nephropathy. N Z Med
J. 2003;116:U566.
36. Rossing K, Jacobsen P, Hommel E, et al. Pregnancy and progression
of diabetic nephropathy. Diabetologia. 2002;45:36-41.
37. Reece EA, Leguizamon G, Homko C. Stringent controls in
diabetic nephropathy associated with optimization of pregnancy
outcomes. J Matern Fetal Med. 1998;7:213-216.
38. Leguizamon G, Reece EA. Effect of medical therapy on progressive
nephropathy: influence of pregnancy, diabetes and
hypertension. J Matern Fetal Med. 2000;9:70-78.
39. Biesenbach G, Grafinger P, Stöger H, et al. How pregnancy
influences renal function in nephropathic type 1 diabetic
women depends on their pre-conceptional creatinine clearance.
J Nephrol. 1999;12:41-46.
40. Gordon M, Landon MB, Samuels P, et al. Perinatal outcome
and long-term follow-up associated with modern management
of diabetic nephropathy. Obstet Gynecol. 1996;87:401-409.
41. Quan A. Fetopathy associated with exposure to angiotensin
converting enzyme inhibitors and angiotensin receptor antagonists.
Early Hum Dev. 2006;82:23-28.
42. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major
congenital malformations after first-trimester exposure to
ACE inhibitors. N Engl J Med. 2006;354:2443-2451.
43. Silfen SL,Wapner RJ, Gabbe SG. Maternal outcome in class H
diabetes mellitus. Obstet Gynecol. 1980;55:749-751.
44. Bagg W, Henley PG, Macpherson P, et al. Pregnancy in women
with diabetes and ischemic heart disease. Aust N Z J Obstet
Gynaecol. 1999;39:99-102.
45. Howorka K, Pumprla J, Gabriel M, et al. Normalization of
pregnancy outcome in pregestational diabetes through functional
insulin treatment and modular out-patient education
adapted for pregnancy. Diabet Med. 2001;18:965-972.
46. Quevedo SF, Coustan DR. Diabetes and pregnancy. Use of an
integrated “team” approach provides the necessary comprehensive
care. R I Med J. 1989;72:129-132.
47. Ray JG, O’Brien TE, Chan WS. Preconception care and the
risk of congenital anomalies in the offspring of women with
diabetes mellitus: a meta-analysis. QJM. 2001;94:435-444.
48. Wilson RD. Pre-conception vitamin/folic acid supplementation
2007: the use of folic acid in combination with a multivitamin
supplement for the prevention of neural tube defects
and other congenital anomalies. J Obstet Gynaecol Can. 2007;29:
1003-1026.
49. Langer O. A spectrum of glucose thresholds may effectively
prevent complications in the pregnant diabetic patient. Semin
Perinatol. 2002;26:196-205.
50. Combs CA, Gunderson E, Kitzmiller JL, et al. Relationship of
fetal macrosomia to maternal postprandial glucose control
during pregnancy. Diabetes Care. 1992;15:1251-1257.
51. de Veciana M, Major CA, Morgan MA, et al. Postprandial versus
preprandial blood glucose monitoring in women with gestational
diabetes mellitus requiring insulin therapy. N Engl J
Med. 1995;333:1237-1241.
52. Langer O, Rodriguez DA, Xenakis EM, et al. Intensified versus
conventional management of gestational diabetes. Am J Obstet
Gynecol. 1994;170:1036-1046.
53. Rosenn BM, Miodovnik M, Khoury JC, et al. Counterregulatory
hormonal responses to hypoglycemia during pregnancy. Obstet
Gynecol. 1996;87:568-574.
54. Diamond MP, Reece EA, Caprio S, et al. Impairment of counterregulatory
hormone responses to hypoglycemia in pregnant
women with insulin-dependent diabetes mellitus. Am J Obstet
Gynecol. 1992;166:70-77.
55. Reece EA, Hagay Z, Roberts AB, et al. Fetal Doppler and
behavioral responses during hypoglycemia induced with the
insulin clamp technique in pregnant diabetic women. Am J